Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127291731 | 12729173 | 1 | I | 20151117 | 20160829 | 20160909 | 20160909 | EXP | GB-MHRA-ADR 23615525 | GB-TEVA-689328ACC | TEVA | 60.00 | YR | Y | 0.00000 | 20160909 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127291731 | 12729173 | 1 | PS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | 1000 MILLIGRAM DAILY; | U | U | 65155 | 500 | MG | BID | ||||||
127291731 | 12729173 | 2 | I | CARBAMAZEPINE. | CARBAMAZEPINE | 1 | MODIFIED RELEASE 400MG IN THE MORNING AND 600MG AT NIGHT. | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127291731 | 12729173 | 1 | Tooth abscess |
127291731 | 12729173 | 2 | Epilepsy |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127291731 | 12729173 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127291731 | 12729173 | Diplopia | |
127291731 | 12729173 | Disorientation | |
127291731 | 12729173 | Dizziness | |
127291731 | 12729173 | Dysarthria | |
127291731 | 12729173 | Labelled drug-drug interaction medication error | |
127291731 | 12729173 | Somnolence | |
127291731 | 12729173 | Vertigo | |
127291731 | 12729173 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |